16K → 15K shares held−4% of their stake
Edwards Lifesciences's SVP, Corporate Controller sold $49K of Edwards Lifesciences shares. Nobody planned it ahead of time.
Traded May 18, 2026 · Filed May 18, 2026
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
option exercise
Code M — exercise or conversion of a derivative security
None found in footnotes
Only flagged when a footnote says so; never inferred
16K → 15K shares held−4% of their stake
Edwards Lifesciences's SVP, Corporate Controller sold $49K of Edwards Lifesciences shares. Nobody planned it ahead of time.
122K → 99K shares held−19% of their stake
Edwards Lifesciences's CVP,Strategy/Corp Development sold $2M of Edwards Lifesciences shares. Nobody planned it ahead of time.
46K → 44K shares held−3% of their stake
Edwards Lifesciences's CVP, TMTT & Surgical sold $127K of Edwards Lifesciences shares. Nobody planned it ahead of time.